Washington Trust Bank held its position in Aetna Inc. (NYSE:AET) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,094 shares of the company’s stock at the end of the second quarter. Washington Trust Bank’s holdings in Aetna were worth $470,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Quadrature Capital Ltd acquired a new position in Aetna during the fourth quarter worth $662,000. Hudson Bay Capital Management LP acquired a new position in Aetna during the fourth quarter worth $3,100,000. Pegasus Partners Ltd. raised its position in Aetna by 2.2% in the fourth quarter. Pegasus Partners Ltd. now owns 7,013 shares of the company’s stock worth $870,000 after buying an additional 153 shares during the last quarter. Teachers Advisors LLC raised its position in Aetna by 2.2% in the fourth quarter. Teachers Advisors LLC now owns 510,395 shares of the company’s stock worth $63,294,000 after buying an additional 10,940 shares during the last quarter. Finally, Kentucky Retirement Systems purchased a new position in Aetna during the fourth quarter worth $3,158,000. 91.73% of the stock is currently owned by hedge funds and other institutional investors.

Aetna Inc. (NYSE AET) traded up 0.13% during trading on Monday, hitting $156.99. 1,283,443 shares of the stock traded hands. The company has a market cap of $52.07 billion, a P/E ratio of 47.88 and a beta of 0.54. Aetna Inc. has a 52-week low of $104.59 and a 52-week high of $157.79. The firm has a 50-day moving average price of $153.22 and a 200 day moving average price of $137.42.

Aetna (NYSE:AET) last issued its quarterly earnings data on Thursday, August 3rd. The company reported $3.42 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.34 by $1.08. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The firm had revenue of $15.52 billion for the quarter, compared to analysts’ expectations of $15.34 billion. During the same quarter in the prior year, the business earned $2.21 EPS. The business’s quarterly revenue was down 2.7% on a year-over-year basis. On average, equities analysts expect that Aetna Inc. will post $9.38 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, July 28th. Stockholders of record on Thursday, July 13th were paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.27%. The ex-dividend date was Tuesday, July 11th. Aetna’s dividend payout ratio (DPR) is presently 43.67%.

COPYRIGHT VIOLATION WARNING: This piece of content was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of international copyright laws. The legal version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/08/07/aetna-inc-aet-stake-held-by-washington-trust-bank-updated.html.

A number of research analysts recently weighed in on the stock. Royal Bank Of Canada raised their price target on shares of Aetna from $162.00 to $171.00 and gave the company an “outperform” rating in a research report on Friday. Jefferies Group LLC reissued a “hold” rating and set a $163.00 price target on shares of Aetna in a research report on Friday. Deutsche Bank AG raised their price target on shares of Aetna from $157.00 to $163.00 and gave the company a “hold” rating in a research report on Monday. Credit Suisse Group reissued an “outperform” rating and set a $165.00 price target (up from $160.00) on shares of Aetna in a research report on Thursday, July 13th. Finally, BidaskClub lowered shares of Aetna from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Eight equities research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $155.78.

In other news, Chairman Mark T. Bertolini sold 103,547 shares of the stock in a transaction that occurred on Wednesday, May 17th. The shares were sold at an average price of $140.79, for a total value of $14,578,382.13. Following the transaction, the chairman now owns 659,888 shares in the company, valued at approximately $92,905,631.52. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Margaret M. Mccarthy sold 27,028 shares of the firm’s stock in a transaction that occurred on Wednesday, June 7th. The stock was sold at an average price of $149.23, for a total transaction of $4,033,388.44. Following the sale, the executive vice president now owns 33,563 shares in the company, valued at approximately $5,008,606.49. The disclosure for this sale can be found here. 1.14% of the stock is owned by corporate insiders.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Stock Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related stocks with our FREE daily email newsletter.